Article
Germline testing data validate inferences of mutational status for variants detected from tumor-only sequencing
2021-04-15
Abstract excerpt
<h4>Structured Abstract</h4> <h4>Background</h4> Pathogenic germline variants (PGV) in cancer susceptibility genes are usually identified in cancer patients through germline testing of DNA from blood or saliva: their detection can impact patient treatment options and potential risk reduction strategies for relatives. PGV can also be identified, in tumor sequencing assays, often performed without matched normal s...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 294e92fd-d7ff-5dc8-93ef-3186b7d410f9
- DOI
- 10.1101/2021.04.14.439855
